Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
1011 On Other Exchanges
Symbol
Exchange
1011 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

china nt pharma group co ltd (1011) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA NT PHARMA GROUP CO LTD (1011)

Related News

No related news articles were found.

china nt pharma group co ltd (1011) Related Businessweek News

No Related Businessweek News Found

china nt pharma group co ltd (1011) Details

China NT Pharma Group Company Limited, together with its subsidiaries, operates as a third-party promotional and sales services provider of pharmaceuticals and vaccines in the People’s Republic of China. It operates in three segments: Third-Party Pharmaceutical Promotion and Sales; Proprietary Products Production and Sales; and Third-Party Vaccines and Other Pharmaceuticals. The Third-Party Pharmaceutical Promotion and Sales segment engages in selling and marketing third-party manufactured pharmaceutical products to customers, as well as providing marketing and promotion services. The Proprietary Products Production and Sales segment is involved in the production and sale of NT branded products and generic drugs. The Third-Party Vaccines and Other Pharmaceuticals segment provides supply chain services for pharmaceutical/vaccine products. The company also offers logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Shanghai, the People's Republic of China.

497 Employees
Last Reported Date: 04/20/15
Founded in 1995

china nt pharma group co ltd (1011) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: CNY4.8M
Executive Director
Total Annual Compensation: --
Honorary Advisor
Total Annual Compensation: CNY2.0M
Compensation as of Fiscal Year 2014.

china nt pharma group co ltd (1011) Key Developments

China NT Pharma Group Company Limited Provides Group Earnings Guidance for the Six Months Ended June 30, 2015

China NT Pharma Group Company Limited provided group earnings guidance for the six months ended June 30, 2015. For the six months, the company announced that based on the preliminary assessment of the unaudited consolidated management accounts of the company for the six months ended 30 June 2015, the group expects to record a substantial increase in net profit by more than 1,400% for the six months ended 30 June 2015 as compared to the same period of 2014. Such increase is primarily attributable to the significant improvement of gross profit margin of its proprietary products and decrease of finance cost.

China NT Pharma Group Company Limited, Special/Extraordinary Shareholders Meeting, Jul 02, 2015

China NT Pharma Group Company Limited, Special/Extraordinary Shareholders Meeting, Jul 02, 2015., at 15:00 China Standard Time. Location: Suite 2418, 24/F. Agenda: To approve the placing agreement; to approve the subscription agreement; to authorise any one Director to exercise all the powers of the company and to take all steps as might in their opinion be desirable or necessary in connection with the placing agreement and the subscription agreement to, including without limitation, allot and issue the placing shares and the subscription shares; and to approve all other transactions contemplated under the placing agreement and the subscription agreement.

China NT Pharma Group Company Limited Announces Executive Changes, Effective from May 10, 2015

The board of directors of China NT Pharma Group Company Limited announced that Ms. Mok Ming Wai has tendered her resignation as the company secretary and authorized representative of the Company with effect from 10 May 2015. The Board announced that Mr. Chiu has been appointed as successor to take up the role of Ms. Mok as the company secretary and authorized representative of the Company with effect from 10 May 2015. Mr. Chiu, aged 37, joined the Group in April 2015 as the Group's Chief Financial Officer. He is responsible for the overall financial management and control, accounting, auditing, corporate financing, investor relations and listing rules compliance of the Group. Mr. Chiu has over 13 years of experience in corporate financing, investor relations, auditing, accounting and financial management. Prior to joining the Group, Mr. Chiu was vice president, chief financial officer and company secretary of a company listed on the Main Board of the Stock Exchange.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1011:HK $1.94 HKD +0.02

1011 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1011.
View Industry Companies
 

Industry Analysis

1011

Industry Average

Valuation 1011 Industry Range
Price/Earnings 100.0x
Price/Sales 1.9x
Price/Book 7.8x
Price/Cash Flow 1,147.4x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA NT PHARMA GROUP CO LTD, please visit www.ntpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.